NCT03142074

Brief Summary

An aortic aneurysm (thoracic or abdominal) is a permanent dilatation of the aorta caused by weakening in the arterial wall. The feared complication is aortic rupture or dissection, leading to potentially lethal aortic bleeding and associated with mortality rates up to 95%. The current diagnosis criteria do not suffice, therefore the goal of this study is the development of an improved biomechanics-based and microstructural-based diagnostic tool.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
180

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
4 months until next milestone

First Posted

Study publicly available on registry

May 5, 2017

Completed
8.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

July 1, 2024

Status Verified

June 1, 2024

Enrollment Period

8.9 years

First QC Date

October 6, 2016

Last Update Submit

June 28, 2024

Conditions

Keywords

Improve diagnosis

Outcome Measures

Primary Outcomes (1)

  • Data collection of patients suffering from thoracic aortic aneurysms

    General information (age, gender, height, weight, BMI); medicinal usage (beta-blockers, ACE inhibitors, statins, angiotensin receptor blockers, ...); cardiovascular risk factors (smoking, hypertension, dyslipidemia, diabetes, atrial fibrillation); cardiovascular properties (tricuspid aortic valve, inherited aortopathies, abdominal aortic aneurysm, prior open heart surgery, ...)

    6 years

Secondary Outcomes (1)

  • Investigation of correlation between rupture risk and mechanical and microstructural parameters

    6 years

Study Arms (1)

Ascending thoracic aortic aneurysm

Biomechanical and microstructural analysis of ATAA ECG-gated CT

Other: Biomechanical and microstructural analysis of ATAARadiation: ECG-gated CT

Interventions

Tissue collection; microstructural testing of tissue; mechanical testing of tissue .

Ascending thoracic aortic aneurysm
ECG-gated CTRADIATION

Image analysis of ECG-gated CT.

Ascending thoracic aortic aneurysm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients suffering from ATAA

You may qualify if:

  • Patients suffering from thoracic aortic aneurysms (ATAA), asymptomatic or symptomatic.
  • Patients with ruptured ATAA undergoing an emergency surgery.
  • Signed informed consent.

You may not qualify if:

  • Patients with ruptured ATAA due to trauma.
  • The presence of any aneurysm feature that will prevent the collection of tissue samples suitable for the biomechanical and microstructural studies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UZ Leuven

Leuven, Vlaams Brabant, 3000, Belgium

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Aneurysmatic tissue

MeSH Terms

Conditions

Aortic Aneurysm, Thoracic

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic Diseases

Study Officials

  • Bart Meuris, PhD

    UZ Leuven

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Amber Hendrickx, MSc

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2016

First Posted

May 5, 2017

Study Start

January 1, 2017

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

July 1, 2024

Record last verified: 2024-06

Locations